OCEAN Trial: Ablate Afib. Assess. Anticoagulate? 🌊
Dr RR Baliga's "Got Knowledge Doc" Podkast
November 12, 20253m 53s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
🌊 OCEAN Trial offers fresh insight into antithrombotic therapy after successful AF ablation. In 1284 patients followed for 3 years, event rates were remarkably low 🌟. Rivaroxaban did not show superiority over aspirin for preventing stroke, systemic embolism, or covert embolic events, while bleeding risk was higher with anticoagulation.
🧠 96% had no new infarcts on MRI at follow-up.
Published in NEJM (2025) — a valuable contribution to nuanced AF post-ablation care.